Higher pharmaceutical public expenditure after direct price control: improved access or induced demand? The Colombian case
Crossref DOI link: https://doi.org/10.1186/s12962-018-0092-0
Published Online: 2018-03-02
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Prada, Sergio I.
Soto, Victoria E.
Andia, Tatiana S.
Vaca, Claudia P.
Morales, Álvaro A.
Márquez, Sergio R.
Gaviria, Alejandro
Article History
Received: 24 September 2017
Accepted: 13 February 2018
First Online: 2 March 2018